|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Descriptive Information Fields | |||||||||
| Brief Title † | Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease | ||||||||
| Official Title † | Continuing Care and Treatment for Patients in the Center for Cancer Research | ||||||||
| Brief Summary | This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol. |
||||||||
| Detailed Description | This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol. |
||||||||
| Study Phase | |||||||||
| Study Type † | Observational | ||||||||
| Study Design † | |||||||||
| Primary Outcome Measure † | |||||||||
| Secondary Outcome Measure † | |||||||||
| Condition † | Acquired Immunodeficiency Syndrome Neoplasm Skin Disease HIV Infections |
||||||||
| Intervention † | |||||||||
| MEDLINE PMIDs | |||||||||
| Links | NIH Clinical Center Detailed Web Page ![]() |
||||||||
| Recruitment Information Fields | |||||||||
| Recruitment Status † | Recruiting | ||||||||
| Enrollment † | |||||||||
| Start Date † | January 1992 | ||||||||
| Completion Date | September 2005 | ||||||||
| Eligibility Criteria † |
Eligible patients include those who have been previously enrolled on an approved NCI research protocol. A CCR investigator decides that it is in the best interests of the patient and the NCI for the patient to be enrolled on this protocol and continue to receive care and follow-up at the NIH. The patient or guardian signs the consent. |
||||||||
| Gender | Both | ||||||||
| Ages | |||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts †† |
|
||||||||
| Location Countries † | United States | ||||||||
| Administrative Information Fields | |||||||||
| NCT ID † | NCT00001295 | ||||||||
| Organization ID | 920094 | ||||||||
| Secondary IDs †† | 92-C-0094 | ||||||||
| Study Sponsor † | National Cancer Institute (NCI) | ||||||||
| Collaborators †† | |||||||||
| Investigators † | |||||||||
| Information Provided By | National Institutes of Health Clinical Center (CC) | ||||||||
| Verification Date | September 2005 | ||||||||
| First Received Date † | November 3, 1999 | ||||||||
| Last Updated Date | March 4, 2008 | ||||||||